ArticleSouthern medical journal2026
Caroline Labriola, Priya Alagesan, HannahSofia Brown, Frances Wang, Terry Hyslop, Rachel Zuzul, Grace Sekaya, Meira Epplein, Katherine S Garman
Abstract read
In one paragraphArticle in Southern medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Caroline LabriolaFrom the Duke University School of Medicine.
Priya AlagesanFrom the Duke University School of Medicine.
HannahSofia BrownFrom the Duke University School of Medicine.
Frances WangDepartment of Biostatistics & Bioinformatics, Duke University, Durham, North Carolina.
Terry HyslopDepartment of Biostatistics & Bioinformatics, Duke University, Durham, North Carolina.
Rachel ZuzulFrom the Duke University School of Medicine.
Grace SekayaDepartment of Population Health Sciences, Duke University.
Meira EppleinCancer Risk, Detection, and Interception Program, Duke Cancer Institute, Durham, North Carolina.
Katherine S GarmanCancer Risk, Detection, and Interception Program, Duke Cancer Institute, Durham, North Carolina.ORCID 0000-0001-7763-8465 Funding
Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI Laura Fish · 1985 to 2026
$174.8MDUKE TRAINING GRANT IN DIGESTIVE DISEASES AND NUTRITIONT32DK007568 · NIDDK · DUKE UNIVERSITY · PI Katherine Garman, Rodger A. Liddle · 1988 to 2026
$5.6MProject 2: Racial differences in host immune response and gastric carcinogenesis: Translating underlying biology to promote gastric cancer interceptionP20CA251657 · NCI · DUKE UNIVERSITY · PI POLLAK, KATHRYN I · 2020 to 2022
$3.2MIMAGINE: Intestinal Metaplasia And Gastritis INtErception StudyR01DK135169 · NIDDK · DUKE UNIVERSITY · PI Katherine Garman · 2024 to 2026
$2.0MNCI NIH HHS P20 CA251657NCI NIH HHS P30 CA014236NIDDK NIH HHS R01 DK135169NIDDK NIH HHS T32 DK007568
6 · The paper itselfAbstract
objectives
methodsWe analyzed a retrospective cohort of 477 patients with
resultsOverall, eradication testing rates were low after index EGD, with 50% of the 477 patients receiving eradication testing after
conclusionsAlthough guidelines suggest querying prior antibiotic exposures before selecting
Indexed as
Anti-Bacterial AgentsHelicobacter InfectionsHelicobacter pyloriPractice Patterns, Physicians'AgedClarithromycinDrug Therapy, CombinationEndoscopy, Digestive SystemFemaleHumansMaleMetronidazoleMiddle AgedProton Pump InhibitorsRetrospective StudiesUnited StatesAnti-Bacterial AgentsClarithromycinMetronidazoleProton Pump Inhibitors
Identifiers
PMID41627957
PMCPMC13307131
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390